AI eye in the scope: singapore study tests smarter polyp spotting
NCT ID NCT05822895
First seen May 06, 2026 · Last updated Jun 18, 2026 · Updated 9 times
Summary
This study looks at whether an artificial intelligence (AI) system called GI Genius can help doctors find more polyps during colonoscopy. Polyps are small growths in the colon that can sometimes turn into cancer. The study will involve 764 adults in Singapore and will compare how many polyps doctors find with and without the AI tool. The goal is to see if the AI makes colonoscopy more effective at preventing colorectal cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLONIC POLYP are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sengkang General Hospital
RECRUITINGSingapore, Singapore, 544886, Singapore
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.